Abstract
Neurofeedback training was performed consisting of rewarding and encouraging 12–15 Hz brainwaves (SMR), while simultaneously discouraging 4–7 Hz brainwaves (theta) and 22–30 Hz brainwaves (high beta) in the right dorsal posterior quadrant of the brain (T4, P4) for 20 half-hour NFB sessions to determine the impact on cortisol levels, DHEA-S levels, scores on the Symptom Checklist-90-R (SCL-90-R), the quality of life inventory, and acute attack medication usage for a Hereditary Angioedema patient.
Similar content being viewed by others
References
Banerji, A. (2013). The burden of illness in patients with hereditary angioedema. Annals of Allergy, Asthma and Immunology, 111(5), 329–336.
Barnes, L., & Johnson, R. (2001). Review of the quality of life inventory. In B. Plake & J. Impara (Eds.), The fourteenth mental measurements yearbook (pp. 974–975). Lincoln, NE: Buros Institute of Mental Measurements.
Caro, X. J., & Winter, E. F. (2011). EEG biofeedback treatment improves certain attention and somatic symptoms in fibromyalgia: A pilot study. Applied Psychophysiology Biofeedback, 36(3), 193–200.
Cicardi, M., Bork, K., Caballero, T., Craig, T., Li, H. H., Longhurst, H., & Zingale, L. (2012). Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an international working group. Allergy: European Journal of Allergy and Clinical Immunology, 67(2), 147–157.
Craig, T., Pürsün, E. A., Bork, K., Bowen, T., Boysen, H., Farkas, H., & Maurer, M. (2012). WAO guideline for the management of hereditary angioedema. World Allergy Organization Journal, 5(12), 182–199.
Derogatis, L. R. (1983). SCL-90-R administration, scoring and procedures manual II for the revised version and other instruments of the psychopathology rating scale series. Baltimore, MD: Clinical Psychometric Research.
Fouche, A. S., Saunders, E. F. H., & Craig, T. (2013). Depression and anxiety in patients with hereditary angioedema. Annals of Allergy, Asthma and Immunology, 13, S1081–S1206.
Frisch, M. B., Clark, M. P., Rouse, S. V., Rudd, M. D., Paweleck, J. K., Greenstone, A., & Kopplin, D. A. (2005). Predictive and treatment validity of life satisfaction and the quality of life inventory. Assessment, 12(1), 66–78.
Gadinger, M. C., Loerbroks, A., Schneider, S., Thayer, J. F., & Fischer, J. E. (2011). Associations between job strain and the Cortisol/DHEA-S ratio among management and nonmanagement personnel. Psychosomatic Medicine, 73(1), 44–52.
Gomide, M. A. C. M. S., Toledo, E., Valle, S. O. R., Campos, R. A., França, A. T., Gomez, N. P., & Grumach, A. S. (2013). Hereditary angioedema: Quality of life in Brazilian patients. Clinics, 68(1), 81–83.
Gruzelier, J. H. (2013). Differential effects on mood of 12–15 (SMR) and 15–18 (beta1) hz neurofeedback. International Journal of Psychophysiology, 12, S0167–S8760.
Hammond, D. (2011). What is neurofeedback: An update. Journal of Neurotherapy: Investigations in Neuromodulation, Neurofeedback and Applied Neuroscience, 15(4), 305–336.
Jolles, S., Williams, P., Carne, E., Mian, H., Huissoon, A., Wong, G., & El-Shanawany, T. (2014). A UK national audit of hereditary and acquired angioedema. Clinical and Experimental Immunology, 175(1), 59–67.
Lennartsson, A. K., Theorell, T., Kushnir, M. M., Bergquist, J., & Jonsdottir, I. H. (2013). Perceived stress at work is associated with attenuated DHEA-S response during acute psychosocial stress. Psychoneuroendocrinology, 38(9), 1650–1657.
Lumry, W. R., Castaldo, A. J., Vernon, M. K., Blaustein, M. B., Wilson, D. A., & Horn, P. T. (2010). The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. Allergy and Asthma Proceedings : The Official Journal of Regional and State Allergy Societies, 31(5), 407–414.
Macginnitie, A. J. (2013). Pediatric hereditary angioedema. Pediatric Allergy and Immunology. doi:10.1111/pai.12168.
Masterpasqua, F., & Healey, K. (2003). Neurofeedback in psychological practice. Professional Psychology : Research and Practice, 34(6), 652–656.
Othmer, S. (2013). Protocol guide for neurofeedback clinicians (4th ed.). Woodland Hills, CA: EEG Info.
Payne, R. (1985). Review of SCL-90-R. In J. V. Mitchell (Ed.), The ninth mental measurement yearbook (pp. 153–156). Lincoln, NE: Buros Institute of Mental Measurements.
Phillips, A. C., Carroll, D., Gale, C. R., Lord, J. M., Arlt, W., & Batty, G. D. (2010). Cortisol, DHEA sulphate, their ratio, and all-cause and cause-specific mortality in the Vietnam experience study. European Journal of Endocrinology, 163(2), 285–292.
Riedl, M. A. (2013). Creating a comprehensive treatment plan for hereditary angioedema. Immunology and Allergy Clinics of North America, 33(4), 471–485.
Riedl, M. A., Bernstein, J. A., Li, H., Reshef, A., Lumry, W., Moldovan, D., & Cicardi, M. (2014). Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: Phase 3, randomized, placebo-controlled trial. Annals of Allergy, Asthma and Immunology, 112(2), 163–169.
Sugaya, N., Izawa, S., Kimura, K., Ogawa, N., Yamada, K. C., Shirotsuki, K., & Shimada, H. (2012). Adrenal hormone response and psychophysiological correlates under psychosocial stress in individuals with irritable bowel syndrome. International Journal of Psychophysiology, 84(1), 39–44.
Thon, V., Härle, P., Schölmerich, J., Kuklinek, P., Lokaj, J., & Straub, R. H. (2007). Lack of dehydroepiandrosterone in type I and II hereditary angioedema and role of danazol in steroid hormone conversion. Allergy: European Journal of Allergy and Clinical Immunology, 62(11), 1320–1325.
Tinius, T. (2007). Research in neurofeedback: Measuring our progress? Journal of Neurotherapy, 11(3), 1–2.
Walford, H. H., & Zuraw, B. L. (2014). Current update on cellular and molecular mechanisms of hereditary angioedema. Annals of Allergy, Asthma and Immunology, 112(5), S1081–S1206.
Wheat, A. L., & Larkin, K. T. (2010). Biofeedback of heart rate variability and related physiology: A critical review. Applied Psychophysiology and Biofeedback, 35(3), 229–242.
Wilson, D. A., Bork, K., Shea, E. P., Rentz, A. M., Blaustein, M. B., & Pullman, W. E. (2010). Economic costs associated with acute attacks and long-term management of hereditary angioedema. Annals of Allergy, Asthma and Immunology, 104(4), 314–320.
Zuraw, B. L., & Christiansen, S. C. (2013). Rare disease partnership. The role of the US HAEA in angioedema care. Immunology and Allergy Clinics of North America, 33(4), 545–553.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burns, S.T. Neurofeedback in Hereditary Angioedema: A Single Case Study of Symptom Reduction. Appl Psychophysiol Biofeedback 40, 251–256 (2015). https://doi.org/10.1007/s10484-015-9288-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10484-015-9288-7